Wordt geladen...
Multi-Envelope HIV-1 Vaccine Development: Two Targeted Immune Pathways, One Desired Protective Outcome
In 2016, there were more than 30 million individuals living with HIV-1, ∼1.8 million new HIV-1 infections, and ∼1 million HIV-1-related deaths according to UNAIDS (unaids.org). Hence, a preventive HIV-1 vaccine remains a global priority. The variant envelopes of HIV-1 present a significant obstacle...
Bewaard in:
| Gepubliceerd in: | Viral Immunol |
|---|---|
| Hoofdauteurs: | , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Mary Ann Liebert, Inc.
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5915263/ https://ncbi.nlm.nih.gov/pubmed/29315059 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/vim.2017.0144 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|